Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Multiple Choice

Which of the following is a documented adverse effect of statins?

The main concept here is that muscle-related side effects are a well-documented adverse effect of statins. This category, often described as Statin-Associated Muscle Symptoms (SAMS), encompasses a range from muscle aches (myalgia) to weakness (myopathy) and, in rare cases, the more serious rhabdomyolysis. Because these symptoms are directly linked to statin exposure and can progress to significant complications like kidney injury if severe, they are the hallmark adverse effect clinicians watch for with statin therapy. While mild liver enzyme elevations (hepatotoxicity) can occur with statins, they are less common and usually not as clinically prominent as SAMS. Hypercalcemia and kidney stones are not typical adverse effects of statins, so they don’t fit the pattern of what’s documented with these drugs. In practice, if a patient reports muscle symptoms, clinicians evaluate severity, check CK levels if indicated, consider dose adjustment or switching statins, and monitor closely. That focus on muscle symptoms explains why the muscle-symptom option is the best choice.

The main concept here is that muscle-related side effects are a well-documented adverse effect of statins. This category, often described as Statin-Associated Muscle Symptoms (SAMS), encompasses a range from muscle aches (myalgia) to weakness (myopathy) and, in rare cases, the more serious rhabdomyolysis. Because these symptoms are directly linked to statin exposure and can progress to significant complications like kidney injury if severe, they are the hallmark adverse effect clinicians watch for with statin therapy.

While mild liver enzyme elevations (hepatotoxicity) can occur with statins, they are less common and usually not as clinically prominent as SAMS. Hypercalcemia and kidney stones are not typical adverse effects of statins, so they don’t fit the pattern of what’s documented with these drugs.

In practice, if a patient reports muscle symptoms, clinicians evaluate severity, check CK levels if indicated, consider dose adjustment or switching statins, and monitor closely. That focus on muscle symptoms explains why the muscle-symptom option is the best choice.